Charles Schwab’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Buy
113,383
+8,874
+8% +$39.2K ﹤0.01% 3247
2026
Q1
$377K Sell
104,509
-8,806
-8% -$30.5K ﹤0.01% 3193
2025
Q4
$386K Buy
113,315
+9
+0% +$44 ﹤0.01% 3224
2025
Q3
$769K Sell
113,306
-4
-0% -$33 ﹤0.01% 3037
2025
Q2
$1.54M Buy
113,310
+4,828
+4% +$45.6K ﹤0.01% 2751
2025
Q1
$590K Buy
108,482
+4
+0% +$23 ﹤0.01% 3019
2024
Q4
$537K Buy
108,478
+6,034
+6% +$31.6K ﹤0.01% 3123
2024
Q3
$537K Hold
102,444
﹤0.01% 3129
2024
Q2
$703K Buy
102,444
+82,235
+407% +$752K ﹤0.01% 3056
2024
Q1
$208K Hold
20,209
﹤0.01% 3233
2023
Q4
$168K Hold
20,209
﹤0.01% 3296
2023
Q3
$126K Hold
20,209
﹤0.01% 3333
2023
Q2
$87.9K Hold
20,209
﹤0.01% 3358
2023
Q1
$34.4K Hold
20,209
﹤0.01% 3421
2022
Q4
$39.2K Hold
20,209
﹤0.01% 3406
2022
Q3
$40K Buy
+20,209
New +$48.2K ﹤0.01% 3383
2021
Q3
Sell
-90,891
Closed -$1.07M 3529
2021
Q2
$1.07M Buy
90,891
+9,461
+12% +$109K ﹤0.01% 2900
2021
Q1
$1.29M Buy
+81,430
New +$1.47M ﹤0.01% 2771

Other funds holding LFMD

Charles Schwab's LFMD Position: Q2 2026 in Review

Charles Schwab increased its LifeMD (LFMD) stake by 8.5% in Q2 2026, buying an estimated $39.2K and bringing the position to 113,383 shares worth $468K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

Charles Schwab first reported a position in LFMD in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.54M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Charles Schwab held 113,383 shares of LifeMD worth $468K as of Q2 2026.
  • Charles Schwab bought 8,874 LifeMD shares in Q2 2026, an estimated $39.2K.
  • LifeMD made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3247 holding.
  • Charles Schwab first reported a position in LifeMD in Q1 2021 and has held it in 18 quarters since.
  • Charles Schwab's LifeMD position peaked at $1.54M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.